Sulindac sulfide and NS-398 treatment of HCT-15 and HCA-7 colon cancer cells also showed time- and dosage-dependent activation of the MEK/ERK and p38 MAPKs. This evidence concerns the gene MAP2K7 and colonic neoplasm.